Breast cancer in the setting of fertility-sparing treatment for endometrial cancer

• Progesterone therapy is a commonly used alternative to surgical management for women with endometrial cancer who desire fertility preservation. • Prior research suggests that progestins may contribute to breast tumorigenesis. • We report a patient diagnosed with progesterone receptor positive brea...

Descripción completa

Detalles Bibliográficos
Autores principales: Moss, Haley A., Frey, Melissa K., Blank, Stephanie V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434147/
https://www.ncbi.nlm.nih.gov/pubmed/26075999
http://dx.doi.org/10.1016/j.gore.2014.10.002
_version_ 1782371734764126208
author Moss, Haley A.
Frey, Melissa K.
Blank, Stephanie V.
author_facet Moss, Haley A.
Frey, Melissa K.
Blank, Stephanie V.
author_sort Moss, Haley A.
collection PubMed
description • Progesterone therapy is a commonly used alternative to surgical management for women with endometrial cancer who desire fertility preservation. • Prior research suggests that progestins may contribute to breast tumorigenesis. • We report a patient diagnosed with progesterone receptor positive breast cancer during hormonal treatment of endometrial cancer.
format Online
Article
Text
id pubmed-4434147
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-44341472015-06-05 Breast cancer in the setting of fertility-sparing treatment for endometrial cancer Moss, Haley A. Frey, Melissa K. Blank, Stephanie V. Gynecol Oncol Rep Case Report • Progesterone therapy is a commonly used alternative to surgical management for women with endometrial cancer who desire fertility preservation. • Prior research suggests that progestins may contribute to breast tumorigenesis. • We report a patient diagnosed with progesterone receptor positive breast cancer during hormonal treatment of endometrial cancer. Elsevier 2014-10-27 /pmc/articles/PMC4434147/ /pubmed/26075999 http://dx.doi.org/10.1016/j.gore.2014.10.002 Text en © 2014 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Case Report
Moss, Haley A.
Frey, Melissa K.
Blank, Stephanie V.
Breast cancer in the setting of fertility-sparing treatment for endometrial cancer
title Breast cancer in the setting of fertility-sparing treatment for endometrial cancer
title_full Breast cancer in the setting of fertility-sparing treatment for endometrial cancer
title_fullStr Breast cancer in the setting of fertility-sparing treatment for endometrial cancer
title_full_unstemmed Breast cancer in the setting of fertility-sparing treatment for endometrial cancer
title_short Breast cancer in the setting of fertility-sparing treatment for endometrial cancer
title_sort breast cancer in the setting of fertility-sparing treatment for endometrial cancer
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434147/
https://www.ncbi.nlm.nih.gov/pubmed/26075999
http://dx.doi.org/10.1016/j.gore.2014.10.002
work_keys_str_mv AT mosshaleya breastcancerinthesettingoffertilitysparingtreatmentforendometrialcancer
AT freymelissak breastcancerinthesettingoffertilitysparingtreatmentforendometrialcancer
AT blankstephaniev breastcancerinthesettingoffertilitysparingtreatmentforendometrialcancer

Ejemplares similares